NYSE:ADCT | Cash Flow Statement | ADC Therapeutics SA

Complete source-backed cash-flow history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$16.57M
2026-03-31-$32.97M-$29.71M$32,000.00-$32,000.00-$583,000.00
2025-12-31-$6.41M-$31.12M$0.00$659,000.00$57.09M
2025-09-30-$40.97M
2025-06-30-$56.65M
2025-03-31-$38.6M-$56.33M$264,000.00-$264,000.00$271,000.00
2024-12-31-$30.73M-$21.85M$90,000.00-$90,000.00-$1.12M
2024-09-30-$43.97M
2024-06-30-$36.54M
2024-03-31-$46.61M-$44.1M$531,000.00-$531,000.00$356,000.00
2023-12-31-$85.03M-$31.63M$327,000.00-$327,000.00-$1,000.00
2023-09-30-$46.73M
2023-06-30-$48.92M
2023-03-31-$59.37M-$15.39M$1.02M-$1.02M$425,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$142.62M-$141.17M$264,000.00$395,000.00$150.95M
2024-12-31-$157.85M-$123.84M$867,000.00-$867,000.00$97.05M
2023-12-31-$240.05M-$118.69M$3.22M-$3.22M$73.88M
2022-12-31-$157.13M-$138.31M$687,000.00-$687,000.00-$897,000.00